$245 Million is the total value of Callan Capital, LLC's 68 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NK | Nantkwest Inc | $23,406,000 | -24.3% | 3,763,086 | 0.0% | 9.56% | -26.3% | |
| BDX | Becton Dickinson & Co | $2,161,000 | +11.7% | 12,740 | 0.0% | 0.88% | +8.8% | |
| IEV | Ishares S&P Euro 350 Idx | $1,716,000 | -3.4% | 45,418 | 0.0% | 0.70% | -5.9% | |
| MON | Monsanto Co New Del | $631,000 | +17.9% | 6,098 | 0.0% | 0.26% | +15.2% | |
| RLY | Spdr Ssga Exch Traded Fd | $490,000 | +4.9% | 20,130 | 0.0% | 0.20% | +2.0% | |
| MLPX | Global X MLP & Energy Infrastr | $449,000 | +20.4% | 32,503 | 0.0% | 0.18% | +17.3% | |
| CMBS | Ishares Etf | $421,000 | +2.4% | 7,910 | 0.0% | 0.17% | 0.0% | |
| EBND | Spdr Barclays Etf | $376,000 | +3.3% | 13,503 | 0.0% | 0.15% | +0.7% | |
| CELG | Celgene Corp | $306,000 | -1.3% | 3,100 | 0.0% | 0.12% | -3.8% | |
| IVV | Ishares TRUST S&P | $215,000 | +1.9% | 1,020 | 0.0% | 0.09% | 0.0% | |
| DEPO | Depomed Inc | $210,000 | +40.9% | 10,700 | 0.0% | 0.09% | +38.7% | |
| SQNM | Sequenom Inc New | $162,000 | -34.9% | 176,777 | 0.0% | 0.07% | -36.5% | |
| HNGR | HANGER INC | $155,000 | +14.8% | 20,836 | 0.0% | 0.06% | +10.5% | |
| BAC | Bank Of America Corp | $133,000 | -1.5% | 10,009 | 0.0% | 0.05% | -5.3% | |
| Aptose Biosciences New | $29,000 | -19.4% | 12,000 | 0.0% | 0.01% | -20.0% | ||
| BIOC | Biocept Inc | $25,000 | -49.0% | 37,736 | 0.0% | 0.01% | -52.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INTL EQUITY INDEX F | 42 | Q3 2023 | 25.5% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 5.8% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 3.8% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 3.4% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 3.4% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 2.7% |
| Vanguard Mid Cap | 42 | Q3 2023 | 2.7% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 2.7% |
| SELECT SECTOR SPDR TR | 42 | Q3 2023 | 1.8% |
| Ishares Tr Dj US Finl | 42 | Q3 2023 | 1.0% |
View Callan Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-04 |
| 13F-HR/A | 2023-06-13 |
| 13F-HR/A | 2023-06-13 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Callan Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.